Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aza spiro decane and use thereof in treating CNS disorders

Aza spiro decane and use thereof in treating CNS disorders

US Patent 5227488 · Granted Jul 13, 1993

Estimated economic value: $802,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia2024
Pulsatile drug delivery system for treating morning akinesia2024
Composition comprising suplatast tosilate2023
Suplatast tosilate for use in the treatment of cough associated with interstitia2023
Use of buspirone metabolites2022
Small molecule modulators of IL-172022
Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodie2022
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia2021
Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors2021
Combinations of serotonin receptor agonists for treatment of movement disorders2020
Orally available pharmaceutical formulation suitable for improved management of 2020